XML 49 R35.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation, Stock Options and Stock Appreciation Rights Award Activity
The following table presents certain information related to the activity of our non-vested stock option grants:
Number of Stock OptionsWeighted Average Exercise PricesWeighted Average Remaining Contractual Term (years)Aggregate Intrinsic Value
Outstanding as of December 31, 2020144,006 $13.00 8.77 $— 
Granted— — — — 
  Less: Forfeited21,777 10.49 — — 
  Less: Expired— — — — 
Less: Exercised
— — — — 
Outstanding as of March 31, 2021122,229 $13.44 8.30 $— 
Vested as of March 31, 2021(1)
90,190 $19.11 7.06 $— 
Exercisable as of March 31, 202130,596 $19.11 7.06 $— 
Schedule of Nonvested Share Activity
The following table presents certain information related to the activity of our non-vested common stock grants:
Number of Restricted SharesWeighted Average Grant Date Fair Value
Outstanding as of December 31, 2020259,006 $10.06 
Granted 79,214 5.97 
Less: Forfeited26,723 10.47 
Less: Vested 9,418 17.57 
Outstanding as of March 31, 2021302,079 $8.72 
Share-based Payment Arrangement, Activity
The following table presents our total stock-based compensation expense:
Three Months Ended March 31,
20212020
Employee stock-based compensation expense
     Pre-tax $163 $526 
     Post-tax (1)
129 416 
Director stock-based compensation expense
     Pre-tax 97 174 
     Post-tax (1)
77 137 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The following weighted-average assumptions were used to value the stock options granted:
2021
Expected annual dividend yield1.70  %
Expected volatility41.59  %
Risk-free interest rate2.35  %
Expected term6